From Medscape Oncology
Coverage from the
Gastrointestinal Cancers Symposium (GICS) 2017
January 19 - 21, 2017; San Francisco, California
- GICS Biomarkers Identified for Celecoxib Chemoprevention in CRC
- GICS Cabozantinib for Carcinoid and Pancreatic NETs: 'Encouraging'
- GICS Nivolumab Continues to Boost Survival in Liver Cancer
- GICS Phase 2 Trials in Pancreatic Cancer: Missing the Mark
Popular News from GICS 2016
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.